High-Risk and Complex PCI: What’s in a Name?

Faculty and Program

	Aditya Bharadwaj, MBBS, FSCAI MCS Use for High-Risk PCI: Optimal Decision-Making		Antonious Attallah, MD, FSCAI Intravascular Imaging: See What You Treat
	M. Babar Basir, DO, FSCAI Calcium Modification: Strategies and Technologies		Rhian E. Davies, DO, FSCAI Multidisciplinary Heart Team Approach to Coronary Revascularization
	Perwaiz M. Meraj, MD Complications: Plan, Prevent, Manage		Emmanouil S. Brilakis, MD, PhD, FSCAI CHIP “Mindset” Moderator
	Megha Prasad, MD How to Train for the Future

Learning Objectives

Upon completion of this activity, participants will be able to:

Examine a multi-disciplinary heart team approach to coronary revascularization.
Review strategies and technologies for calcium modification.
Describe intravascular imaging protocols.
Discuss MCS use for high-risk PCI.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 2.0 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Disclosures

Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships were mitigated before the start of the activity.

Planner
Emmanouil Brilakis: Advisory Board and Speaker with Abbott and Cardiovascular Systems Inc; Advisory Board with GE Healthcare, and Medtronic; Consulting with Cardiovascular Systems Inc and IMDS; Speaker with Asahi, Biotronik, Boston Scientific, IMDS, Siemens, and Teleflex; PI with GE Healthcare

Faculty
Antonious Attallah: Speaker with Philips

Aditya Bharadwaj: Consulting and Speaker with Abiomed, Cardiovascular Systems Inc, and Shockwave

Emmanouil Brilakis: Advisory Board and Speaker with Abbott and Cardiovascular Systems Inc; Advisory Board with GE Healthcare, and Medtronic; Consulting with Cardiovascular Systems Inc and IMDS; Speaker with Asahi, Biotronik, Boston Scientific, IMDS, Siemens, and Teleflex; PI with GE Healthcare

Rhian Davies: Advisory Board and Speaker with Boston Scientific and Medtronic; Speaker with Abiomed, Asahi Intecc, and Siemens Healthineers

Anbukarasi Maran: Advisory Board with Teleflex; Speaker with Boston Scientific, Cardiovascular Systems Inc, Medtronic, and Philips

Perwaiz Meraj: Advisory Board with Abiomed and Cardiovascular Systems Inc

Megha Prasad: Consulting with Abbott

Reviewers
Charles Bruen, Nathan Hall, Kasia Hryniewica, Sara Martinez, and Anezi Uzendu: No relevant financial relationships with ineligible companies.

Staff
Robert Bartel, Rebecca Burwell, and Laura Porter: No relevant financial relationships with ineligible companies.

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process
SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships. SCAI identifies relevant financial relationships and mitigates them before the activity begins.

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.

Summary

Availability:

On-Demand

Access expires on Jul 31, 2026

Cost:

FREE

Credit Offered:

2 CME Credits

2 ABIM-MOC Points

2 Participation Credits